Menu Menu

RVNC    Revance Therapeutics Inc    1479290    
Income Statement
Revenue rvnc-20240930 59,879,000
Net Income rvnc-20240930 -38,115,000
Profit Margin -63.65%

Balance Sheet
Current Assets 329,687,000
Assets 461,564,000
Current Liabilities 80,049,000
Liabilities 624,594,000
Equity -163,030,000

Cash Flow Statement
Operating Cash Flow -148,157,000
Investing Cash Flow -15,305,000

Market Analysis
BVPS 15.68
PB 0.10
PS 2.59
FCF -163,462,000
Dividends
Jan Feb Mar
Apr May Jun
Jul Aug Sep
Oct Nov Dec

Earnings
Jan Feb Mar
2/28 0.62
Apr May Jun
5/09 -0.58
Jul Aug Sep
8/08 -0.36
Oct Nov Dec
11/7 -0.37

Find a discrepancy? The most accurate way to find company fundamental data is to view RVNC documents filed with the SEC.


RVNC Filings       Clear



Find balance sheet, income statement, market analysis, and dividend information by typing the ticker symbol of a company.

Ticker:



View A List of Tickers





We can also help with your taxes.

Formal Tax

www.formal.tax





(402) 804-8293


Formal Financial App
Google Play - Apple Store

created using: Admin Canvas